Results 161 to 170 of about 160,486 (260)

A novel method using the level of mobility to predict mortality in patients admitted for decompensated cirrhosis: A prospective study

open access: yes, 2022
Liver Transplantation, EarlyView.
Andrew J. Groff   +5 more
wiley   +1 more source

Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis. [PDF]

open access: yesWien Klin Wochenschr, 2020
Wakolbinger R   +8 more
europepmc   +1 more source

Mode‐of‐Action and Human Relevance Assessment for Diisononyl Phthalate‐Induced Liver Tumors in Rodents

open access: yesJournal of Applied Toxicology, EarlyView.
ABSTRACT Diisononyl phthalate (DINP) is a high molecular weight phthalate and high production volume chemical. DINP's carcinogenic potential has been investigated in four rodent bioassays, with liver tumors observed in three of the studies. Authoritative assessments have hypothesized that DINP acts through the peroxisome proliferator‐activated receptor
Amanda N. Buerger   +3 more
wiley   +1 more source

Correction to: Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis. [PDF]

open access: yesWien Klin Wochenschr, 2020
Wakolbinger R   +8 more
europepmc   +1 more source

Biochemical and Molecular Insights Into Monocrotaline‐Induced Hepatotoxicity: An Experimental Mouse Study

open access: yesJournal of Applied Toxicology, EarlyView.
ABSTRACT Monocrotaline (MCT), a plant‐derived pyrrolizidine alkaloid, is well known for its hepatotoxic effects. However, full elucidation of the mechanisms underlying MCT‐induced hepatotoxicity, as well as the development of reliable biomarkers for early detection and monitoring, requires an integrated evaluation of biochemical, molecular, and ...
Ali Şenol   +4 more
wiley   +1 more source

Serum Vascular Adhesion Protein-1 and Endothelial Dysfunction in Hepatic Cirrhosis: Searching for New Prognostic Markers. [PDF]

open access: yesInt J Mol Sci
Fasolato S   +11 more
europepmc   +1 more source

A Comprehensive Study of Bidirectional Interactions Between the Human Microbiome and Blood Malignancies and Hematologic Conditions: Focus on Novel Therapeutic Strategies

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Microbiota‐targeted therapeutic strategies in hematological disorders. aHSCT: Transplanted immune cells from the donor may attack the recipient's tissues, especially when damage to the intestinal epithelium disrupts the gut microbiota, contributing to GVHD. Maintaining a balanced gut microbiota that supports immune regulation helps reduce GVHD risk and
Alireza Molajafari   +3 more
wiley   +1 more source

Hepatic cirrhosis

open access: yes, 2009
Victor J. Navarro   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy